Cart
sales@molnova.com
Transcainide
CAS No. 88296-62-2
Transcainide( —— )
Catalog No. M34139 CAS No. 88296-62-2
Transcainide(R 54718), a new lidocaine analog, is an orally active antiarrhythmic agent.Transcainide blocks the open state of BTX-activated sodium channels in bovine heart and rat skeletal muscle.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 378 | In Stock |
|
| 10MG | 538 | In Stock |
|
| 25MG | 791 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTranscainide
-
NoteResearch use only, not for human use.
-
Brief DescriptionTranscainide(R 54718), a new lidocaine analog, is an orally active antiarrhythmic agent.Transcainide blocks the open state of BTX-activated sodium channels in bovine heart and rat skeletal muscle.
-
DescriptionTranscainide (R 54718) is an orally active antiarrhythmic agent.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMembrane Transporter/Ion Channel
-
TargetSodium Channel
-
RecptorSodium Channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number88296-62-2
-
Formula Weight373.53
-
Molecular FormulaC22H35N3O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(NC1=C(C)C=CC=C1C)(=O)C2(N(C)C)CCN(CC2)[C@H]3[C@H](O)CCCC3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. R Stroobandt, Evaluation of the efficacy and tolerance of the antiarrhythmic agent transcainide (R 54718). Eur J Clin Pharmacol. 1987;32(5):449-56.?
molnova catalog
related products
-
Oxybuprocaine hydroc...
Oxybuprocaine hydrochloride is a local anesthetic, which is used especially in ophthalmology and otolaryngology.
-
Lacosamide
An anticonvulsant compound that enhances the slow inactivation of voltage-gated sodium channels without affecting the fast inactivation of voltage-gated sodium channels.
-
Elpetrigine
Elpetrigine (GW273293) is a potential sodium channel blocker with antiepileptic activity that can be used to study epilepsy.
